Impact of time from transplant to treatment of patients with refractory cytomegalovirus infection: post hoc analysis of Phase 3 SOLTICE study

被引：0
|
作者：
Chemaly, R.
Avery, R.
Dadwal, S.
Kamar, N.
Maertens, J.
Papanicolaou, G. A.
Witzke, O.
Gu, J.
Auciello, J.
机构：
来源：
SWISS MEDICAL WEEKLY | 2022年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P24
引用
收藏
页码：8S / 8S
页数：1
相关论文
共 50 条
  • [41] Safety and Effectiveness of Diazepam Nasal Spray With Concomitant Cannabidiol: Post Hoc Analysis of Pediatric Patients From a Phase 3 Safety Study
    Peters, J.
    Puri, V
    Segal, E.
    Misra, S.
    Rabinowicz, A.
    Carrazana, E.
    ANNALS OF NEUROLOGY, 2023, 94 : S60 - S61
  • [42] Neutropenia and efficacy outcomes in patients with refractory mCRC: A post-hoc analysis of the phase III SUNLIGHT trial
    Prager, G.
    Tabernero, J.
    Fakih, M.
    Ciardiello, F.
    Van Cutsem, E.
    Roby, L.
    Yao, W.
    Choucair, E.
    Taieb, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S18 - S19
  • [43] PREDICTORS OF BISOPROLOL ON-TREATMENT STATUS AT THE TIME OF INCLUSION OF HYPERTENSIVE PATIENTS IN THE STUDY: POST-HOC ANALYSIS OF THE TRICOLOR STUDY
    Logunova, Natalia
    Karpov, Yuri
    Khomitskaya, Yunona
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E98 - E98
  • [44] Impact of hypogammaglobulinemia and immunoglobulin replacement therapy on infection rate in patients with RRMM treated with elranatamab: post-hoc analysis from MagnetisMM-3
    Leleu, Xavier
    Bahlis, Nizar
    Rodriguez-Otero, Paula
    Quach, Hang
    Touzeau, Cyrille
    Depaus, Julien
    Iida, Shinsuke
    Haenel, Mathias
    Wrobel, Tomasz
    Leip, Eric
    Conte, Umberto
    Sullivan, Sharon
    Viqueira, Andrea
    Lesokhin, Alexander
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S194 - S194
  • [45] TREATMENT OUTCOMES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS WITH OR WITHOUT CONCOMITANT THERAPIES: POST HOC ANALYSIS FROM A PHASE 3 TRIAL OF BUDESONIDE ORAL SUSPENSION
    Hirano, Ikuo
    Katzka, David A.
    Collins, Margaret H.
    Wojtowicz, Abigail M.
    Zhang, Wenwen
    Boules, Mena
    Desai, Nirav K.
    Dellon, Evan S.
    GASTROENTEROLOGY, 2021, 160 (06) : S250 - S250
  • [46] MANAGEMENT OF CORTICOSTEROIDS IN PATIENTS RECEIVING RUXOLITINIB TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE: A POST HOC ANALYSIS FROM THE RANDOMIZED PHASE 3 REACH3 STUDY
    Kintsch, Emily
    Xue, Zhenyi
    Galvin, John
    Locatelli, Franco
    Zeiser, Robert
    Bhatt, Valkal
    BONE MARROW TRANSPLANTATION, 2024, 59 : 310 - 310
  • [47] Vedolizumab treatment persistence up to 3 years: post hoc analysis in vedolizumab-naive patients from the GEMINI LTS study
    Vermeire, S.
    Loftus, E. V., Jr.
    Khalid, J. M.
    Tudor, D.
    Akbari, M.
    Demuth, D.
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S30 - S31
  • [48] Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study
    Watanabe, Kenji
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Fujitani, Yasushi
    Faes, Margaux
    Oortwijn, Alessandra
    Lindsay, James O.
    Rogler, Gerhard
    Hibi, Toshifumi
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (06): : 801 - 811
  • [49] IMPACT OF UPADACITINIB OR ADALIMUMAB AS INITIAL THERAPY ON THE ACHIEVEMENT OF 48-WEEK TREATMENT GOALS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: POST HOC ANALYSIS OF A PHASE 3 STUDY
    Mysler, E.
    Tanaka, Y.
    Kavanaugh, A.
    Aletaha, D.
    Taylor, P. C.
    Song, I. H.
    Shaw, T.
    Song, Y.
    Demasi, R.
    Ali, M.
    Fleischmann, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 566 - 567
  • [50] Impact of Upadacitinib or Adalimumab as Initial Therapy on the Achievement of 48-Week Treatment Goals in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate: Post Hoc Analysis of a Phase 3 Study
    Mysler, Eduardo
    Tanaka, Yoshiya
    Kavanaugh, Arthur
    Aletaha, Daniel
    Taylor, Peter
    Song, In-Ho
    Shaw, Tim
    Song, Yanna
    DeMasi, Ryan
    Ali, Mira
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12345